Tuesday, May 26, 2009
Attorney General Announces Eli Lilly Settlement
The state Medicaid program will receive $3.8 million of a settlement reached with Eli Lilly. Tuesday State Attorney General Jack Conway announced a $5.1 million settlement with Eli Lilly, the manufacturer of the anti-psychotic drug Zyprexa. The state claimed the company persuaded physicians to prescribe the drug for pediatric and dementia patients for uses not approved by the U.S. Food and Drug Administration. Under the deal, Eli Lilly will be required to provide samples of the drug to health care providers consistent with FDA approval. For the next six years, Eli Lilly must disclose payments in excess of $100 to promotional speakers and consultants and register all studies and results with the Attorney General's office.